Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers
Introduction
Organophosphate ester hydrolases (OPH) displaying multiple turnover, such as bacterial phosphotriesterases (PTE) and mammalian serum paraoxonases (PON1), have been demonstrated to have the capacity to serve as potential prophylactic drugs to counteract in vivo intoxication by nerve agents and organophosphate-based pesticides [1], [2], [3], [4], [5]. A significant obstacle in applying OPHs as antidotes against nerve agent intoxication is their preference for hydrolysis of the less-toxic isomers of nerve agents with the RP absolute configuration at the phosphorous center [6], [7], [8], [9]. All nerve agents are racemic mixtures due to the chiral phosphorous atom, with the more potent anti-AChE agents, i.e., the toxic isomers, being assigned the absolute configuration S around the P atom (SP) [10]. It should be pointed out, however, that the assignment of the SP configuration to the toxic isomers of sarin (GB), soman (GD), cyclosarin (GF) and VX (all liquids) has been suggested on the basis of deductive stereo-chemistry, and only indirect structural evidence exists to support this contention [11].
The combined application of computational design and directed evolution of mammalian PON1 has the potential to evolve a variant with reversed stereo-preference and kinetic properties that will qualify it to serve as a realistic candidate for prophylactic of nerve agent intoxications. The need to screen huge libraries of mutants, and to rapidly identify and select variants evolved to hydrolyze the toxic isomers, as well as the call for accurate biochemical characterization of kcat and Km of both the SP and RP enantiomers, necessitate the synthesis of the individual fluorogenic optical isomers. The synthesis and biochemical properties of racemic O-alkyl methylphosphonates containing coumarin analogs as the fluorogenic leaving group have already been described [12], [13], [14]. In order to qualify as catalytic scavenger drug candidates, rePON1 variants should be capable of hydrolyzing the toxic OP isomers at kcat/Km ≥ 5 × 107 M−1 min−1 (unpublished calculations). To achieve the desired specificity and efficacy towards the toxic isomers when reacting with racemic nerve agents, it was, therefore, necessary to develop stereo-specific methods for the synthesis of appropriate SP and RP fluorescent surrogates for screening of libraries, for improved selection, and for accurate biochemical characterization of promising catalytic variants.
In this report we describe the synthesis, purity, structural determination and biochemical properties of optical isomers of nerve agents in which the leaving groups fluoride (G agents) and N,N-dialkylaminoethanthiolo (V agents) were replaced by the fluorescent moiety, 3-cyano-7-hydroxy-4-methylcoumarin (CHMC) (Fig. 1). The SP enantiomers were utilized to screen libraries by fluorescence-activated cell sorting and by direct monitoring of the release of the CHMC leaving group by crude lysates in 96-well plates.
Section snippets
Chemicals and enzymes
3-Cyano-7-hydroxy-4-methylcoumarine (CHMC) and l-proline methyl ester hydrochloride were purchased from Aldrich (USA) and used as obtained. Methylphosphonyl dichloride (CH3POCl2) was prepared according to Moedritzer and Miller [15]. Recombinant human AChE (hAChE) was purchased from Sigma (USA) and Torpedo californica AChE (TcAChE) was purified as previously described [16]. Wt rePON1 is variant G3C9 of the gene shuffling products of four mammalian PON1s [17], and its H115W mutant were produced
Stereo-specific synthesis via construction of pairs of diastereoisomers
The separated pair of diastereoisomers which was obtained by reacting CH3POCl2 in a one-pot synthesis with l-proline methyl ester, followed by reaction with CHMC (Fig. 1A), was found by X-ray diffraction to possess the same SC configuration at the chiral proline carbon. The SP and RP configurations at the phosphorous atom were established, and the purified diastereoisomers designated as I-SPSC and I-RPSC, respectively (Table 1). X-ray diffraction showed that reaction with either primary or
Conclusions
The individual stereoisomers of several O-alkyl methylphosphonylated coumarin analogs of nerve agents were prepared by a stereo-specific synthesis protocol, and by an enzymatic procedure that utilized the racemic mixture of the fluorogenic surrogates and a rePON1 mutant that hydrolyze preferentially the RP isomer. The high enantiomeric purity, and the low level of free chromophore suggests that the SP chiral analogs of nerve agents are suitable for screening of large rePON1 libraries for
Conflict of interest
The authors declare that there are no conflicts of interests. (It should be noted that a patent application was submitted with respect to the generation of the rePON1 variants mentioned in this paper.)
Acknowledgements
Financial support by the NIH CounterACT Program (1U54NS058183) and the Defense Threat Reduction Agency (HDTRA 1-07-C-0024) to DST and JLS is gratefully acknowledged.
References (22)
- et al.
Prophylaxis against organophosphate poisoning by an enzyme hydrolyzing organophosphorus compounds in mice
Life Sci.
(1991) - et al.
Protection against tabun intoxication in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters
Biochem. Pharmacol.
(1992) - et al.
OpdA, a bacterial organophosphorus hydrolase, prevents lethality in rats after poisoning with highly toxic organophosphorus pesticides
Toxicology
(2008) - et al.
Stereoselective detoxification of chiral sarin and soman analogues by phosphotriesterase
Bioorg. Med. Chem.
(2001) - et al.
Stereo-specificity in the enzymatic hydrolysis of cyclosarin (GF)
Enzyme Microb. Technol.
(2005) - et al.
Synthesis and anti-cholinesterase activity of some new fluorogenic analogues of organophosphorus nerve agents
J. Fluorine Chem.
(2006) - et al.
Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereo-selectivity
Toxicology
(2007) - et al.
Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C
J. Mol. Biol.
(1988) - et al.
The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases
J. Biol. Chem.
(2006) - et al.
A new and rapid colorimetric determination of acetylcholinesterase activity
Biochem. Pharmacol.
(1961)
Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning
Proc. Natl. Acad. Sci. U.S.A.
Cited by (26)
Applications of phytochemicals against nerve agents in counterterrorism
2021, Phytochemistry, the Military and Health: Phytotoxins and Natural DefensesAutomated Design of Efficient and Functionally Diverse Enzyme Repertoires
2018, Molecular CellDCC-assisted direct esterification of phosphinic and phosphoric acids with O-nucleophiles
2018, Phosphorus, Sulfur and Silicon and the Related ElementsDecontamination of organophosphorus compounds: Towards new alternatives
2017, Annales Pharmaceutiques FrancaisesCDI-promoted direct esterification of P(O)-OH compounds with phenols
2017, Tetrahedron LettersCitation Excerpt :Herein we report this efficient and simple protocol that is more economical and convenient than those reported in the literature for the synthesis of O-aryl organophosphorus compounds without the use of diaryliodonium salts and metal salts. Compared with P(O)-H or P-Cl compounds, P(O)-OH compounds are more air- and/or moisture-stable, and the use of them is more cost-saving and effective (Scheme 1).11–13 The reaction of diphenyl phosphinic acid with phenol at room temperature with the assistance of N,N′-carbonyl diimidazole (CDI) and Et3N in THF under N2 atmosphere gives O-phenyl diphenyl phosphinate 3a in 31% yield (Table 1, entry 1).
Targeting of organophosphorus compound bioscavengers to the surface of red blood cells
2016, Chemico-Biological InteractionsCitation Excerpt :This, in addition to the side-effects from the therapeutics themselves, can leave units temporarily depleted and vulnerable to future attack. The issue of how to treat OP exposures with a minimum of physiological and cognitive consequences has led to the concept and development of OP bioscavengers [4,7–12]. Desirable characteristics for prophylactic bioscavengers include easy administration (i.e., intramuscular rather than intravenous injection), broad specificity, lack of physiological, cognitive, behavioral, or immunological effects, and sustained stability in the circulation.